Related Experiment Video
Updated: Dec 22, 2025
07:21
Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice
Published on: September 28, 2015
38.8K
Angiotensin-Converting Enzyme Inhibitor Angioedema
Josh Bankston1, David Thomas House
1University of Alabama at Birmingham School of Nursing.
Advanced Emergency Nursing Journal
|May 3, 2020
Summary
Angiotensin-converting enzyme inhibitor (ACEI) angioedema is a serious emergency department issue. Fresh frozen plasma shows promise as an initial treatment for this condition.
Area of Science:
- Emergency Medicine
- Pharmacology
Background:
- Angiotensin-converting enzyme inhibitors (ACEIs) are widely prescribed for cardiovascular conditions.
- ACEI-induced angioedema is a rare but potentially life-threatening adverse effect.
- Prompt recognition and management are crucial for patient safety.
Observation:
- This article reviews the clinical presentation, underlying pathology, and diagnostic approaches to ACEI angioedema.
- It specifically examines the emergency department setting where these cases often present.
- Patient education regarding ACEI risks is also discussed.
Findings:
- The review details the characteristic symptoms and diagnostic workup for ACEI-induced angioedema.
- Fresh frozen plasma (FFP) is investigated as a potential first-line treatment modality.
- The efficacy and mechanism of FFP in managing ACEI angioedema are explored.
Implications:
- Understanding ACEI angioedema is vital for emergency physicians.
- Fresh frozen plasma may offer a novel therapeutic option for acute management.
- Improved patient education can mitigate the incidence and severity of this adverse reaction.
Related Concept Videos
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.2K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.2K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.1K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.1K
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
2.2K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.2K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
810
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
810
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
351
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
351
01:28Cardiac Catheterization I: Pre-Procedure Overview
821
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
821